Evidence map›Paper›PMID 31873966›Full record

ArticleGlia2020

Gpr126/Adgrg6 contributes to the terminal Schwann cell response at the neuromuscular junction following peripheral nerve injury.

Albina Jablonka-Shariff, Chuieng-Yi Lu, Katherine Campbell, Kelly R Monk, Alison K Snyder-Warwick

Open access · greenAbstract read
In one paragraph

Article in Glia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Basic Pathological Mechanisms in Peripheral Nerve Diseases.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Heterologous fibrin biopolymer as an emerging approach to peripheral nerve repair: a scoping review.The journal of venomous animals and toxins including tropical diseases · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Lessons from Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Albina Jablonka-ShariffDivision of Plastic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Chuieng-Yi LuDivision of Plastic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Katherine CampbellDivision of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Kelly R MonkDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri.
Alison K Snyder-WarwickDivision of Plastic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0002-9882-4213
Washington University in St. Louis · USChang Gung University · TW

Funding

MOLECULAR AND GENETIC ANALYSIS OF GPR126 IN PERIPHERAL NERVE.R01NS079445 · NINDS · WASHINGTON UNIVERSITY · PI MONK, KELLY R · 2012 to 2020
$3.1M
Investigation of Terminal Schwann Cell Function in Homeostasis and InjuryK08NS096232 · NINDS · WASHINGTON UNIVERSITY · PI SNYDER-WARWICK, ALISON K · 2017 to 2020
$717k
NINDS NIH HHS K08 NS096232NINDS NIH HHS R01 NS079445
6 · The paper itself

Abstract

Gpr126/Adgrg6 is an adhesion G protein-coupled receptor essential for Schwann cell (SC) myelination with important contributions to repair after nerve crush injury. Despite critical functions in myelinating SCs, the role of Gpr126 within nonmyelinating terminal Schwann cells (tSCs) at the neuromuscular junction (NMJ), is not known. tSCs have important functions in synaptic maintenance and reinnervation, and after injury tSCs extend cytoplasmic processes to guide regenerating axons to the denervated NMJ. In this study, we show that Gpr126 is expressed in tSCs, and that absence of Gpr126 in SCs (SC-specific Gpr126 knockout, cGpr126) results in a NMJ maintenance defect in the hindlimbs of aged mice, but not in young adult mice. After nerve transection and repair, cGpr126 mice display delayed NMJ reinnervation, altered tSC morphology with decreased S100β expression, and reduced tSC cytoplasmic process extensions. The immune response promoting reinnervation at the NMJ following nerve injury is also altered with decreased macrophage infiltration, Tnfα, and anomalous cytokine expression compared to NMJs of control mice. In addition, Vegfa expression is decreased in muscle, suggesting that cGpr126 non-cell autonomously modulates angiogenesis after nerve injury. In sum, cGpr126 mice demonstrated delayed NMJ reinnervation and decreased muscle mass following nerve transection and repair compared to control littermates. The integral function of Gpr126 in tSCs at the NMJ provides the framework for new therapeutic targets for neuromuscular disease.

Indexed as

AnimalsMiceMuscle, SkeletalNerve RegenerationNeuromuscular JunctionPeripheral Nerve InjuriesReceptors, CholinergicReceptors, G-Protein-CoupledSchwann CellsGpr126 protein, mouseReceptors, CholinergicReceptors, G-Protein-CoupledGpr126nerve injuryNMJterminal Schwann cells

Identifiers

PMID31873966
PMCPMC7148175
OpenAlexW2998120056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.